Medivir Hosts Expert Perspectives Webcast on the Evolving Treatment Landscape and the Unique Treatment Challenges in HCC

/PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

Related Keywords

Stockholm ,Sweden ,Spain ,Glasgow ,Glasgow City ,United Kingdom ,Barcelona ,Comunidad Autonoma De Cataluna ,Scotland ,Pia Baumann ,Maria Reig ,Jeff Evans ,Magnus Christensen ,Scotland Cancer Research Network ,School Of Cancer Sciences ,Scientific Advisory Council ,Professor Of Translational Cancer Research ,Scotland Cancer Center ,National Clinical ,Scotland Cancer Centre ,Glasgow Experimental Cancer Medicine Centre ,University Of Glasgow ,Beatson West ,Liver Cancer Unit ,Drs Evans ,Translational Cancer Research ,Cancer Sciences ,Honorary Consultant ,Medical Oncology ,National Clinical Lead ,Cancer Research ,Liver Oncology Unit ,Hospital Clinic ,Nasdaq Stockholm ,Small Cap ,European Journal ,Medivir ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,Conference Call Announcements ,